QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Announces Expansion of Investigative Pipeline
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions. The company today announced the expansion of its pipeline into metabolic and related disorders including weight loss and liver health. FSD Pharma has initiated investigations into certain ingredients and combinations of ingredients that show promise in improving liver health, reducing metabolic disease and reducing visceral fat. The company is leading these efforts to potentially create a new exciting product line in addition to unbuzzd(TM). To view the full press release, visit https://ibn.fm/mpMNa About FSD Pharma Inc. FSD is…